DexCom, Insulet Corporation Share Data In Pursuit Of App-Based Diabetes Manager

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Diabetes devices makers Insulet (NSDQ:PODD) and DexCom Inc. (NSDQ:DXCM) agreed this week to deepen their partnership, sharing data between in order to support a “personal diabetes manager” (PDM) system currently in development by Insulet.

Under the new agreement DexCom agreed to share data from its 5th-generation continuous glucose monitors with Insulet’s pending wireless PDM technology, which would mean that patients can trade their separate CGM receivers for a mobile app that captures, stores and displays data.

“We are pleased to expand our development relationship with DexCom to receive and display DexCom G5 Sensor data on our new PDM, eliminating the need to carry a separate CGM receiver,” Insulet president & CEO Duane DeSisto said in prepared remarks.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC